Market moving legal disputes…
MDC's “Event-Driven Legal℠" Weekly Report summarises near-term legal events including analysis on their potential as share-price catalysts for the indicated companies. Recent coverage includes:
Arbutus Biopharma and Genevant Sciences recently filed Patent Infringement Lawsuit against Moderna seeking licensing fees for the manufacture and sale of Moderna’s vaccine for COVID-19.
IDT Corporation's Defense of a shareholder lawsuit challenging the repurchase of an Indemnification Claim from Straight Path Communications that spared it from having to pay $614m in FCC fines.
Sonos and Alphabet's continuing battles at the US International Trade Commission and US District Courts.
Edition: 130
- 04 March, 2022
Healthcare
ABUS should experience high volatility when the US Court of Appeals for the Federal Circuit issues its Decisions in Appellate Case Numbers: 20-1184 & 20-2329. Although Decisions may still be a few months away, these Patents relate to a Nucleic Acid delivery system comprising of a composite of multiple lipids. This delivery system appears to have ranges that overlap with Moderna's recent Covid-19 Vaccine; and therefore, ABUS may have grounds for an eventual Patent Infringement lawsuit.
Edition: 123
- 12 November, 2021